Kiyoshi Okazuka

479 total citations
36 papers, 340 citations indexed

About

Kiyoshi Okazuka is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kiyoshi Okazuka has authored 36 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 17 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Kiyoshi Okazuka's work include Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (9 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Kiyoshi Okazuka is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (9 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Kiyoshi Okazuka collaborates with scholars based in Japan and United Kingdom. Kiyoshi Okazuka's co-authors include Tadao Ishida, Ryo Kominami, Yukio Mishima, Hisami Watanabe, Iekuni Oh, Ken Ohmine, Yuichi Wakabayashi, Jun Inoue, Tsutomu Kanefuji and Shin‐ichiro Fujiwara and has published in prestigious journals such as Blood, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Kiyoshi Okazuka

32 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoshi Okazuka Japan 11 180 160 108 87 43 36 340
Jodie Ulaszek United States 6 106 0.6× 154 1.0× 64 0.6× 66 0.8× 26 0.6× 9 329
Kaiyang Ding China 9 107 0.6× 100 0.6× 113 1.0× 46 0.5× 36 0.8× 51 241
Elisabetta Calistri Italy 7 205 1.1× 66 0.4× 111 1.0× 65 0.7× 19 0.4× 14 308
Pentti Mäntymaa Finland 12 271 1.5× 43 0.3× 127 1.2× 98 1.1× 66 1.5× 31 332
Carmen Martínez‐Chamorro Spain 9 341 1.9× 128 0.8× 173 1.6× 38 0.4× 37 0.9× 15 383
Tiziana Moscato Italy 13 269 1.5× 86 0.5× 174 1.6× 64 0.7× 10 0.2× 33 339
Stephan Bohl Germany 8 159 0.9× 176 1.1× 56 0.5× 89 1.0× 8 0.2× 16 329
Rossana Putzulu Italy 9 133 0.7× 157 1.0× 51 0.5× 27 0.3× 32 0.7× 26 295
Ceren Durer United States 8 134 0.7× 69 0.4× 141 1.3× 69 0.8× 49 1.1× 30 280
Seren Durer United States 8 134 0.7× 66 0.4× 141 1.3× 68 0.8× 49 1.1× 29 273

Countries citing papers authored by Kiyoshi Okazuka

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Okazuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Okazuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Okazuka more than expected).

Fields of papers citing papers by Kiyoshi Okazuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Okazuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Okazuka. The network helps show where Kiyoshi Okazuka may publish in the future.

Co-authorship network of co-authors of Kiyoshi Okazuka

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Okazuka. A scholar is included among the top collaborators of Kiyoshi Okazuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Okazuka. Kiyoshi Okazuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okazuka, Kiyoshi, Tadao Ishida, Jun Sakamoto, et al.. (2021). Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry. Annals of Hematology. 100(12). 2989–2995. 2 indexed citations
2.
Okazuka, Kiyoshi, Tadao Ishida, Yumiko Yoshiki, et al.. (2019). The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma. European Journal Of Haematology. 104(2). 110–115. 9 indexed citations
3.
Okazuka, Kiyoshi, Yumiko Yoshiki, Yu Abe, et al.. (2019). Red blood cell distribution width is a simple and novel biomarker for survival in light-chain amyloidosis. International Journal of Hematology. 110(4). 431–437. 3 indexed citations
4.
Ishida, Tadao, Masahiro Ikeda, Sumito Shingaki, et al.. (2018). [IgE-κ type multiple myeloma achieving complete response with novel agents].. PubMed. 58(11). 2232–2237. 1 indexed citations
5.
Ito, Shoko, Shin‐ichiro Fujiwara, Kiyomi Mashima, et al.. (2017). Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Annals of Hematology. 96(5). 719–724. 9 indexed citations
6.
Umino, Kento, Shin‐ichiro Fujiwara, Kazuya Sato, et al.. (2017). High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica. 137(2). 93–99. 3 indexed citations
8.
Fujiwara, Shin‐ichiro, Kazuo Muroi, Raine Tatara, et al.. (2014). CD25 Expression Is Associated with Inferior Clinical Outcomes in Elderly Patients with Acute Myeloid Leukemia. Blood. 124(21). 3678–3678. 2 indexed citations
9.
Muroi, Kazuo, Shin‐ichiro Fujiwara, Raine Tatara, et al.. (2013). CD56 Expression in Normal Immature Granulocytes after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Clinical and Experimental Hematopathology. 53(3). 247–250. 6 indexed citations
10.
Okazuka, Kiyoshi, et al.. (2012). Features of Japanese patients with myelodysplastic syndrome in an aging population of Sado Island. International Journal of Hematology. 95(4). 420–427.
12.
Abe, Takashi, Tatsuo Furukawa, Masayoshi Masuko, et al.. (2009). Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation. International Journal of Hematology. 90(3). 421–425. 6 indexed citations
13.
Okazuka, Kiyoshi, Masayoshi Masuko, Yoshinobu Seki, et al.. (2007). Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion. International Journal of Hematology. 86(3). 246–249. 11 indexed citations
14.
Okazuka, Kiyoshi, Masayoshi Masuko, Yoshinobu Seki, et al.. (2007). Successful All-trans Retinoic Acid Treatment of Acute Promyelocytic Leukemia in a Patient with NPM/RAR Fusion. International Journal of Hematology. 86(3). 246–249. 16 indexed citations
15.
Furukawa, T, Naoko Sato, Kiyoshi Okazuka, et al.. (2007). Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A. Bone Marrow Transplantation. 40(9). 875–880. 14 indexed citations
16.
Inoue, Jun, Tsutomu Kanefuji, Kiyoshi Okazuka, et al.. (2006). Expression of TCRαβ Partly Rescues Developmental Arrest and Apoptosis of αβ T cells in Bcl11b −/− Mice. The Journal of Immunology. 176(10). 5871–5879. 39 indexed citations
17.
Okazuka, Kiyoshi, Yuichi Wakabayashi, M Kashihara, et al.. (2005). p53 prevents maturation of T cell development to the immature CD4−CD8+ stage in Bcl11b−/− mice. Biochemical and Biophysical Research Communications. 328(2). 545–549. 22 indexed citations
19.
Hashimoto, Shigeo, Ken Toba, Junjiro Tsuchiyama, et al.. (2002). CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigens. Leukemia Research. 26(3). 289–295. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026